+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell and Gene Therapy Thawing Equipment Market by Equipment Category, Technology Architecture, Application Area, Operation Parameter, Safety and Compliance - Global Forecast to 2030- Product Image
Cell and Gene Therapy Thawing Equipment Market by Equipment Category, Technology Architecture, Application Area, Operation Parameter, Safety and Compliance - Global Forecast to 2030- Product Image
Sale

Cell and Gene Therapy Thawing Equipment Market by Equipment Category, Technology Architecture, Application Area, Operation Parameter, Safety and Compliance - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6160720
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The rapid evolution of cell and gene therapies is redefining medical frontiers, propelling unprecedented demand for precise and reliable thawing equipment. As these advanced treatments move from research labs to clinical and commercial settings, the importance of standardized thaw protocols and robust equipment multiplies. Organizations must navigate complex requirements for temperature control, regulatory compliance, and process integration to ensure the viability and safety of delicate cellular products. In this dynamic environment, stakeholders ranging from biobanking facilities to pharmaceutical manufacturers seek solutions that deliver repeatable consistency, reduce manual intervention, and integrate data-driven insights. Consequently, thawing systems that marry automation, intelligent controls, and remote monitoring are emerging as critical enablers for scalable, high-throughput workflows. This introduction lays the groundwork for understanding how cutting-edge thawing technologies are not merely supporting the cell and gene therapy ecosystem but actively transforming it.

Transformative Shifts in the Thawing Equipment Landscape

The landscape of cell and gene therapy thawing solutions has undergone transformative shifts driven by converging technological innovations. Leading the charge, algorithm based control platforms now leverage predictive analytics to anticipate thermal behavior, enabling more precise temperature ramp profiles. Concurrently, feedback control systems have matured to offer closed-loop adjustments that ensure consistency across batches. Remote monitoring systems amplify operational transparency, allowing real-time oversight and data capture from distributed sites. Thermal control units have become more compact and energy-efficient, facilitating integration into automated process lines. Together, these advancements catalyze a move away from manual thaw tools toward hybrid platforms that deliver rapid, consistent thaw cycles with minimal human intervention. As a result, early adopters are reporting improved cell viability, reduced cycle times, and streamlined compliance. The ongoing convergence of smart controls, connectivity, and process automation is setting new benchmarks for reliability and scalability in cell and gene therapy manufacturing.

Cumulative Impact of U.S. Tariffs in 2025

In 2025, newly implemented United States import tariffs on specialized thawing devices have introduced additional cost pressures across the supply chain. Equipment manufacturers face higher material expenses while distribution partners grapple with margin compression. End-users are responding by negotiating long-term service agreements, exploring domestic sourcing alternatives, or consolidating purchases to leverage volume discounts. Simultaneously, some suppliers are localizing critical components or establishing assembly hubs closer to key markets to mitigate customs duties. Although these strategic moves can improve lead times and reduce logistical complexity, they also demand upfront capital investments and supply chain reengineering. Ultimately, while tariffs have driven short-term cost increases, they are accelerating the adoption of diversified procurement strategies and stimulating regional manufacturing capabilities, which may yield greater resilience and cost predictability over the long term.

Key Segmentation Insights for Thawing Equipment

A nuanced view of the thawing equipment market emerges when segmenting by equipment category, technology architecture, application area, operation parameter, and safety and compliance. Across automated thaw devices, hybrid thaw platforms, manual thaw tools, and rapid thaw systems-particularly those featuring intelligent thawing systems-buyers are prioritizing consistency and throughput. Algorithm based control, feedback control systems, remote monitoring, and thermal control units-with predictive analytics embedded within algorithm based offerings-are redefining how thermal profiles are managed, yielding unprecedented precision. In application contexts such as biobanking, cell processing facilities, clinical research-especially experimental therapy-pharmaceutical manufacturing, and stem cell research, organizations are seeking solutions that seamlessly integrate into their existing workflows without compromising product integrity. Process automation, temperature ramp profiles, thaw consistency, and time efficiency remain critical operation parameters, with data driven optimization augmenting automation to continuously refine cycle parameters. On the safety front, quality assurance, regulatory adherence-enhanced through smart compliance systems-and sterility maintenance are non-negotiable priorities, prompting vendors to embed digital traceability and automated audit trails into their platforms.

Key Regional Insights Shaping Market Demand

Regional dynamics in the thawing equipment market reflect distinct adoption rates, regulatory frameworks, and investment appetites. In the Americas, a robust biopharma infrastructure and aggressive pipeline growth are driving early adoption of advanced thawing platforms, while tariff-induced cost pressures are prompting localized production and strategic sourcing. Europe, the Middle East, and Africa present a complex mosaic of regulatory guidelines; stringent quality standards in the EU and expanding clinical research hubs across the Middle East are catalyzing demand for flexible systems that comply with diverse local requirements. In the Asia-Pacific region, rapid expansion of stem cell research and contract manufacturing organizations in countries like China, Japan, and Australia is fueling investments in automation and remote monitoring solutions. These regional trends highlight the importance of aligning product portfolios with evolving regulatory landscapes and local market priorities.

Competitive Landscape and Key Player Developments

The competitive arena for thawing equipment features a diverse mix of established corporations and agile innovators. Advanced Thawing Technologies Corp and Apex Cell Preservation Inc. are pioneering high-throughput automation, while BioCell Dynamics LLC and BioCryo Solutions LLC focus on compact, benchtop systems optimized for smaller facilities. BioThaw Equipment Corp, Cell Process Instruments LLC, and Cell Revival Medical Corp emphasize modular platforms that support rapid integration into existing workflows. Companies such as CellEquip Solutions Inc and CellGene Instruments Inc differentiate through advanced thermal control units and remote monitoring capabilities, and CellGene Thaw Systems Inc and CellGenesis Technologies LLC are known for custom philanthropic collaborations targeting academic research labs. Emerging players including CellRegen Solutions LLC and CryoCell Innovators Inc are pushing the envelope with predictive analytics, whereas CryoEquip Technologies Inc and CryoGene Systems Inc leverage smart compliance systems to streamline regulatory reporting. High-performance offerings from CryoThaw Inc and Dynamic Thaw Systems Ltd are gaining traction in commercial manufacturing, just as GenCell Instruments Incorporated, GeneCell Dynamics Ltd, and GeneCell Preservation Systems Inc are expanding service networks across key regions. GeneCryo Equipment Inc, GeneFreeze Solutions Corp, and GeneTherm Solutions Inc have entered strategic partnerships to enhance data driven optimization, while Innovative Thawing Solutions Corp, Precision Cell Recovery LLC, and ThawAdvance Technologies Ltd focus on bespoke solutions for clinical research. Finally, ThawTech Industries Inc., ThermoCell Recovery Ltd., ThermoCell Systems Ltd., and ThermoGene Research Ltd. are investing heavily in R&D to deliver next-generation thawing platforms that integrate AI-driven recommendations and ensure long-term viability of cell and gene therapy products.

Actionable Recommendations for Industry Leaders

To maintain leadership in this rapidly evolving market, industry decision-makers should pursue several strategic actions. First, invest in next-generation algorithm based control systems enhanced with predictive analytics to optimize thaw consistency and reduce manual interventions. Second, expand partnerships with remote monitoring providers to deliver real-time data insights and accelerate troubleshooting across distributed sites. Third, reinforce supply chain resilience by exploring localized manufacturing or forging alliances with multiple suppliers to mitigate tariff impacts. Fourth, integrate smart compliance systems that automate audit trails and regulatory documentation, ensuring seamless adherence to evolving quality standards. Fifth, tailor product roadmaps to meet region-specific requirements, prioritizing modular designs for regions with diverse regulatory landscapes. Finally, cultivate cross-industry collaborations-linking biobanking, clinical research, and pharmaceutical manufacturing stakeholders-to co-develop solutions that address end-to-end workflow challenges and create unified thawing ecosystems.

Conclusion: Navigating the Next Wave of Innovation

The thawing equipment sector stands at a pivotal juncture, where technology, regulation, and global trade dynamics converge to shape the future of cell and gene therapy manufacturing. Through continuous innovation in algorithm based control, predictive analytics, and remote connectivity, suppliers can deliver solutions that address both throughput demands and stringent quality requirements. Meanwhile, stakeholders must adapt procurement strategies to navigate tariff implications and regional regulatory nuances. By aligning product development with operational priorities-process automation, data driven optimization, and smart compliance-organizations will be well positioned to enhance cell viability, improve time efficiency, and accelerate therapeutic outcomes. This executive summary underscores the critical importance of strategic foresight and collaborative partnerships in driving the next wave of growth for the thawing equipment market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Equipment Category
    • Automated Thaw Devices
    • Hybrid Thaw Platforms
    • Manual Thaw Tools
    • Rapid Thaw Systems
      • Intelligent Thawing Systems
  • Technology Architecture
    • Algorithm Based Control
      • Predictive Analytics
    • Feedback Control Systems
    • Remote Monitoring Systems
    • Thermal Control Units
  • Application Area
    • Biobanking
    • Cell Processing Facilities
    • Clinical Research
      • Experimental Therapy
    • Pharmaceutical Manufacturing
    • Stem Cell Research
  • Operation Parameter
    • Process Automation
      • Data Driven Optimization
    • Temperature Ramp Profiles
    • Thaw Consistency
    • Time Efficiency
  • Safety and Compliance
    • Quality Assurance
    • Regulatory Adherence
      • Smart Compliance Systems
    • Sterility Maintenance
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Advanced Thawing Technologies Corp
  • Apex Cell Preservation Inc.
  • BioCell Dynamics LLC
  • BioCryo Solutions LLC
  • BioThaw Equipment Corp
  • Cell Process Instruments LLC
  • Cell Revival Medical Corp
  • CellEquip Solutions Inc
  • CellGene Instruments Inc
  • CellGene Thaw Systems Inc
  • CellGenesis Technologies LLC
  • CellRegen Solutions LLC
  • CryoCell Innovators Inc
  • CryoEquip Technologies Inc
  • CryoGene Systems Inc.
  • CryoThaw Inc
  • Dynamic Thaw Systems Ltd
  • GenCell Instruments Incorporated
  • GeneCell Dynamics Ltd
  • GeneCell Preservation Systems Inc
  • GeneCryo Equipment Inc
  • GeneFreeze Solutions Corp
  • GeneTherm Solutions Inc
  • Innovative Thawing Solutions Corp
  • Precision Cell Recovery LLC
  • ThawAdvance Technologies Ltd
  • ThawTech Industries Inc.
  • ThermoCell Recovery Ltd.
  • ThermoCell Systems Ltd.
  • ThermoGene Research Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell And Gene Therapy Thawing Equipment Market, by Equipment Category
8.1. Introduction
8.2. Automated Thaw Devices
8.3. Hybrid Thaw Platforms
8.4. Manual Thaw Tools
8.5. Rapid Thaw Systems
8.5.1. Intelligent Thawing Systems
9. Cell And Gene Therapy Thawing Equipment Market, by Technology Architecture
9.1. Introduction
9.2. Algorithm Based Control
9.2.1. Predictive Analytics
9.3. Feedback Control Systems
9.4. Remote Monitoring Systems
9.5. Thermal Control Units
10. Cell And Gene Therapy Thawing Equipment Market, by Application Area
10.1. Introduction
10.2. Biobanking
10.3. Cell Processing Facilities
10.4. Clinical Research
10.4.1. Experimental Therapy
10.5. Pharmaceutical Manufacturing
10.6. Stem Cell Research
11. Cell And Gene Therapy Thawing Equipment Market, by Operation Parameter
11.1. Introduction
11.2. Process Automation
11.2.1. Data Driven Optimization
11.3. Temperature Ramp Profiles
11.4. Thaw Consistency
11.5. Time Efficiency
12. Cell And Gene Therapy Thawing Equipment Market, by Safety And Compliance
12.1. Introduction
12.2. Quality Assurance
12.3. Regulatory Adherence
12.3.1. Smart Compliance Systems
12.4. Sterility Maintenance
13. Americas Cell And Gene Therapy Thawing Equipment Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Thawing Technologies Corp
16.3.2. Apex Cell Preservation Inc.
16.3.3. BioCell Dynamics LLC
16.3.4. BioCryo Solutions LLC
16.3.5. BioThaw Equipment Corp
16.3.6. Cell Process Instruments LLC
16.3.7. Cell Revival Medical Corp
16.3.8. CellEquip Solutions Inc
16.3.9. CellGene Instruments Inc
16.3.10. CellGene Thaw Systems Inc
16.3.11. CellGenesis Technologies LLC
16.3.12. CellRegen Solutions LLC
16.3.13. CryoCell Innovators Inc
16.3.14. CryoEquip Technologies Inc
16.3.15. CryoGene Systems Inc.
16.3.16. CryoThaw Inc
16.3.17. Dynamic Thaw Systems Ltd
16.3.18. GenCell Instruments Incorporated
16.3.19. GeneCell Dynamics Ltd
16.3.20. GeneCell Preservation Systems Inc
16.3.21. GeneCryo Equipment Inc
16.3.22. GeneFreeze Solutions Corp
16.3.23. GeneTherm Solutions Inc
16.3.24. Innovative Thawing Solutions Corp
16.3.25. Precision Cell Recovery LLC
16.3.26. ThawAdvance Technologies Ltd
16.3.27. ThawTech Industries Inc.
16.3.28. ThermoCell Recovery Ltd.
16.3.29. ThermoCell Systems Ltd.
16.3.30. ThermoGene Research Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET MULTI-CURRENCY
FIGURE 2. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET MULTI-LANGUAGE
FIGURE 3. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY AUTOMATED THAW DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY HYBRID THAW PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY MANUAL THAW TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY INTELLIGENT THAWING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY FEEDBACK CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REMOTE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY THERMAL CONTROL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CELL PROCESSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EXPERIMENTAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY DATA DRIVEN OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TEMPERATURE RAMP PROFILES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY THAW CONSISTENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TIME EFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SMART COMPLIANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STERILITY MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 73. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 75. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 76. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 77. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 78. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 79. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 81. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 124. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 125. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 127. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 128. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 129. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 130. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 131. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 132. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 133. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 134. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 135. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 137. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 138. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 139. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 140. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 141. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 143. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 155. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 215. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 219. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 220. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 259. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 270. FINLAND

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell and Gene Therapy Thawing Equipment market report include:
  • Advanced Thawing Technologies Corp
  • Apex Cell Preservation Inc.
  • BioCell Dynamics LLC
  • BioCryo Solutions LLC
  • BioThaw Equipment Corp
  • Cell Process Instruments LLC
  • Cell Revival Medical Corp
  • CellEquip Solutions Inc
  • CellGene Instruments Inc
  • CellGene Thaw Systems Inc
  • CellGenesis Technologies LLC
  • CellRegen Solutions LLC
  • CryoCell Innovators Inc
  • CryoEquip Technologies Inc
  • CryoGene Systems Inc.
  • CryoThaw Inc
  • Dynamic Thaw Systems Ltd
  • GenCell Instruments Incorporated
  • GeneCell Dynamics Ltd
  • GeneCell Preservation Systems Inc
  • GeneCryo Equipment Inc
  • GeneFreeze Solutions Corp
  • GeneTherm Solutions Inc
  • Innovative Thawing Solutions Corp
  • Precision Cell Recovery LLC
  • ThawAdvance Technologies Ltd
  • ThawTech Industries Inc.
  • ThermoCell Recovery Ltd.
  • ThermoCell Systems Ltd.
  • ThermoGene Research Ltd

Related Topics

Related Reports

Cell and Gene Therapy Supply Chain Software Market Report and Forecast 2025-2034 - Product Image

Cell and Gene Therapy Supply Chain Software Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Cell Therapy Technologies Market by Offering (Consumables, Equipment, Software & Services), Therapy Type (Allogeneic Cell Therapy, Autologous Cell Therapy, Gene-Modified Cell Therapy), Manufacturing Process, Delivery Method, Application, End User - Global Forecast 2025-2030 - Product Image

Cell Therapy Technologies Market by Offering (Consumables, Equipment, Software & Services), Therapy Type (Allogeneic Cell Therapy, Autologous Cell Therapy, Gene-Modified Cell Therapy), Manufacturing Process, Delivery Method, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cell & Gene Therapy Services Market by Service Type (Analytical Services, Development Services, Manufacturing Services), Technology Platform (Gene Editing, Nonviral Delivery, Viral Vectors), Therapy Type, End User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Services Market by Service Type (Analytical Services, Development Services, Manufacturing Services), Technology Platform (Gene Editing, Nonviral Delivery, Viral Vectors), Therapy Type, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type (Analytical Services, Clinical Manufacturing, Commercial Manufacturing), Therapy Type (Cell Therapy, Gene Therapy), Technology, Application, Scale, End User, Process Stage - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type (Analytical Services, Clinical Manufacturing, Commercial Manufacturing), Therapy Type (Cell Therapy, Gene Therapy), Technology, Application, Scale, End User, Process Stage - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Gene Therapy for Sickle Cell Disease Market by Treatment Model (Allogeneic, Autologous), Modification Technology (Base Editing, Cripr/Cas9, Lentiviral Vector), Patient Age, Severity, Payer Category, Distribution Channel - Global Forecast 2025-2030 - Product Image

Gene Therapy for Sickle Cell Disease Market by Treatment Model (Allogeneic, Autologous), Modification Technology (Base Editing, Cripr/Cas9, Lentiviral Vector), Patient Age, Severity, Payer Category, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.